Jailendra Singh
Stock Analyst at Truist Securities
(0.94)
# 3,771
Out of 4,893 analysts
174
Total ratings
28.89%
Success rate
-23.46%
Average return
Main Sectors:
Stocks Rated by Jailendra Singh
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| HNGE Hinge Health | Initiates: Buy | $48 | $44.14 | +8.74% | 1 | Jun 16, 2025 | |
| PHR Phreesia | Maintains: Buy | $34 → $35 | $28.67 | +22.08% | 6 | May 29, 2025 | |
| TDOC Teladoc Health | Maintains: Hold | $10 → $9 | $8.81 | +2.16% | 16 | May 27, 2025 | |
| DOCS Doximity | Maintains: Hold | $58 → $52 | $60.08 | -13.45% | 8 | May 16, 2025 | |
| WAY Waystar Holding | Maintains: Buy | $45 → $50 | $37.64 | +32.84% | 2 | May 8, 2025 | |
| MEDP Medpace Holdings | Maintains: Hold | $333 → $300 | $328.24 | -8.60% | 4 | Apr 23, 2025 | |
| IQV IQVIA Holdings | Maintains: Buy | $263 → $216 | $165.53 | +30.49% | 15 | Apr 10, 2025 | |
| ICLR ICON Public Limited Company | Maintains: Buy | $262 → $208 | $152.07 | +36.78% | 9 | Apr 10, 2025 | |
| PRVA Privia Health Group | Maintains: Buy | $27 → $28 | $21.09 | +32.76% | 7 | Apr 10, 2025 | |
| HIMS Hims & Hers Health | Maintains: Hold | $39 → $33 | $50.27 | -34.35% | 9 | Apr 10, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Hold | $6.5 → $5.5 | $4.90 | +12.24% | 12 | Apr 10, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $15 → $14 | $11.23 | +24.67% | 5 | Apr 10, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Hold | $12 → $7.5 | $8.39 | -10.61% | 7 | Apr 10, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $50 → $46 | $25.61 | +79.62% | 5 | Mar 18, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Hold | $261 → $210 | $281.64 | -25.44% | 7 | Jan 13, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Hold | $26 → $19 | $23.61 | -19.53% | 9 | Nov 13, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $17 → $14 | $13.80 | +1.45% | 1 | Jul 2, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Hold | $6.4 → $6.5 | $2.31 | +181.39% | 8 | May 24, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Neutral | $16 → $13 | $4.14 | +214.01% | 11 | May 4, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Neutral | $42 → $43 | $8.28 | +419.32% | 6 | Feb 28, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Neutral | $30 → $24 | $4.19 | +473.48% | 2 | Feb 24, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Neutral | $14 → $4 | $2.42 | +65.29% | 4 | Feb 8, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Neutral | $60 → $58 | $162.17 | -64.24% | 2 | Feb 4, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Underperform | $90 → $45 | $6.01 | +648.75% | 7 | Jan 7, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Upgrades: Outperform | $230 → $333 | $714.54 | -53.40% | 6 | Jan 7, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Neutral | $10 → $9 | $3.05 | +195.08% | 2 | May 19, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Underperform | n/a | $21.48 | - | 3 | Jan 15, 2021 |
Hinge Health
Jun 16, 2025
Initiates: Buy
Price Target: $48
Current: $44.14
Upside: +8.74%
Phreesia
May 29, 2025
Maintains: Buy
Price Target: $34 → $35
Current: $28.67
Upside: +22.08%
Teladoc Health
May 27, 2025
Maintains: Hold
Price Target: $10 → $9
Current: $8.81
Upside: +2.16%
Doximity
May 16, 2025
Maintains: Hold
Price Target: $58 → $52
Current: $60.08
Upside: -13.45%
Waystar Holding
May 8, 2025
Maintains: Buy
Price Target: $45 → $50
Current: $37.64
Upside: +32.84%
Medpace Holdings
Apr 23, 2025
Maintains: Hold
Price Target: $333 → $300
Current: $328.24
Upside: -8.60%
IQVIA Holdings
Apr 10, 2025
Maintains: Buy
Price Target: $263 → $216
Current: $165.53
Upside: +30.49%
ICON Public Limited Company
Apr 10, 2025
Maintains: Buy
Price Target: $262 → $208
Current: $152.07
Upside: +36.78%
Privia Health Group
Apr 10, 2025
Maintains: Buy
Price Target: $27 → $28
Current: $21.09
Upside: +32.76%
Hims & Hers Health
Apr 10, 2025
Maintains: Hold
Price Target: $39 → $33
Current: $50.27
Upside: -34.35%
Apr 10, 2025
Maintains: Hold
Price Target: $6.5 → $5.5
Current: $4.90
Upside: +12.24%
Apr 10, 2025
Maintains: Buy
Price Target: $15 → $14
Current: $11.23
Upside: +24.67%
Apr 10, 2025
Maintains: Hold
Price Target: $12 → $7.5
Current: $8.39
Upside: -10.61%
Mar 18, 2025
Maintains: Buy
Price Target: $50 → $46
Current: $25.61
Upside: +79.62%
Jan 13, 2025
Maintains: Hold
Price Target: $261 → $210
Current: $281.64
Upside: -25.44%
Nov 13, 2024
Downgrades: Hold
Price Target: $26 → $19
Current: $23.61
Upside: -19.53%
Jul 2, 2024
Maintains: Buy
Price Target: $17 → $14
Current: $13.80
Upside: +1.45%
May 24, 2024
Maintains: Hold
Price Target: $6.4 → $6.5
Current: $2.31
Upside: +181.39%
May 4, 2022
Maintains: Neutral
Price Target: $16 → $13
Current: $4.14
Upside: +214.01%
Feb 28, 2022
Maintains: Neutral
Price Target: $42 → $43
Current: $8.28
Upside: +419.32%
Feb 24, 2022
Maintains: Neutral
Price Target: $30 → $24
Current: $4.19
Upside: +473.48%
Feb 8, 2022
Downgrades: Neutral
Price Target: $14 → $4
Current: $2.42
Upside: +65.29%
Feb 4, 2022
Maintains: Neutral
Price Target: $60 → $58
Current: $162.17
Upside: -64.24%
Jan 7, 2022
Downgrades: Underperform
Price Target: $90 → $45
Current: $6.01
Upside: +648.75%
Jan 7, 2022
Upgrades: Outperform
Price Target: $230 → $333
Current: $714.54
Upside: -53.40%
May 19, 2021
Maintains: Neutral
Price Target: $10 → $9
Current: $3.05
Upside: +195.08%
Jan 15, 2021
Downgrades: Underperform
Price Target: n/a
Current: $21.48
Upside: -